dm+d

108471007

Articles

Parkinson’s disease medicines formulations for adults with swallowing difficulties

13 June 2022Guidance to help you ensure your patients with Parkinson’s Disease are able to get the most from their medicines if they develop swallowing difficulties

Safety in Lactation: Dopaminergic drugs used in Parkinsons disease

25 September 2020Although rare, Parkinson’s disease can occur in younger women of childbearing age. Dopamine receptor agonists are used either alone or as an adjunct to levodopa…
Search Articles

Medicine Compliance Aid Stability

genericAccord Healthcare Ltd

Accord Healthcare Ltd
generic
Tablets 88 micrograms, 180 micrograms, 350 micrograms, 700 micrograms
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from moisture
Extremely sensitive to light. Keep covered. Protect from moisture. Max 7 days in a MCA.
26 October 2015

MirapexinBoehringer Ingleheim

Boehringer Ingleheim
Mirapexin
Tablets 88 micrograms, 180 micrograms, 350 micrograms, 700 micrograms
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from moisture
Extremely sensitive to light. Keep covered. Protect from moisture. Max 7 days in a MCA
26 October 2015

Mirapexin Prolonged ReleaseBoehringer Ingelheim

Boehringer Ingelheim
Mirapexin Prolonged Release
Tablets m/r 260 micrograms, 520 micrograms, 1.05mg, 1.57mg, 2.1mg , 2.62mg, 3.15mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from moisture
Protect from moisture. Max 14 days in a MCA.
26 October 2015

Lactation Safety Information

No
Levodopa, (as co-beneldopa or co-careldopa)
May interfere with lactation
No published evidence of safety
Dopamine receptor agonist
18 September 2020